Shadow AI in Healthcare: How Leaders Can Reduce Risk Without Blocking Innovation
- 4 days ago
- 7 min read
Artificial intelligence is becoming easier to access across healthcare, pharma, digital health, and life sciences. Employees can now use generative AI tools to draft documents, summarize information, analyze data, support coding, create patient-facing materials, and accelerate administrative workflows.
That access creates opportunity.
It also creates risk.
One of the fastest-growing AI governance challenges is shadow AI: the use of AI tools outside approved policies, systems, or oversight processes.
For healthcare and life sciences organizations, shadow AI is not just an IT issue. It is a privacy, safety, compliance, equity, cybersecurity, and accountability issue.
The goal is not to ban AI. The goal is to create clear guardrails so teams can use AI responsibly.
What Is Shadow AI?
Shadow AI occurs when staff use AI tools without formal approval, documentation, or governance review.
This may include:
entering patient, research, or business data into public AI tools
using unapproved chatbots to draft clinical or operational content
relying on AI-generated summaries without review
using AI tools embedded in vendor platforms without understanding how they work
uploading confidential documents into external AI systems
using AI for coding, documentation, recruitment, analytics, or communication outside approved workflows
In many cases, staff are not acting with bad intent. They are trying to save time, reduce administrative burden, or solve practical workflow problems.
That is why shadow AI needs governance, not just restriction.
Why Shadow AI Matters in Healthcare
Healthcare data are sensitive. Clinical workflows are high stakes. Research and life sciences environments require documentation, integrity, privacy, and accountability.
When AI tools are used without oversight, organizations may not know:
what data are being entered
where those data are stored
whether data are used to train future models
whether outputs are accurate
whether outputs are biased or misleading
whether patient-facing content has been reviewed
whether regulatory or contractual requirements are being met
who is accountable if the AI output causes harm
The HIPAA Security Rule requires covered entities and business associates to protect electronic protected health information through administrative, physical, and technical safeguards. That obligation becomes harder to meet when staff use AI tools outside approved systems.
Shadow AI can also introduce security risks. The OWASP Top 10 for Large Language Model Applications highlights risks such as prompt injection, insecure output handling, training data poisoning, sensitive information disclosure, and excessive agency. These risks matter when generative AI tools are connected to healthcare data, workflows, or enterprise systems.
Where Shadow AI Shows Up
Shadow AI can appear in many parts of an organization.
In healthcare delivery, staff may use AI tools to draft patient instructions, summarize notes, prepare emails, translate content, or organize clinical information. In pharma and life sciences, teams may use AI to support literature review, clinical trial documentation, protocol summaries, medical affairs materials, commercial planning, or internal analytics.
Common shadow AI use cases include:
clinical documentation support
patient communication drafts
meeting summaries
grant or manuscript drafting
research protocol review
clinical trial recruitment support
vendor proposal analysis
data cleaning or analysis
coding support
marketing or educational content
policy or compliance drafting
Some of these uses may be low risk. Others may be high risk depending on the data involved, the workflow affected, and whether outputs are reviewed before use.
This is why organizations need risk-based governance.
The Risk of Overcorrecting
A common response to shadow AI is to prohibit broad AI use.
That may feel safe, but it can create a different problem. If staff believe approved pathways are too slow, unclear, or unrealistic, they may continue using AI tools without disclosure.
In practice, overly restrictive policies can push AI use further underground.
A better approach is to define:
approved AI tools
prohibited uses
data that may never be entered into public tools
low-risk uses that are allowed with guidance
high-risk uses that require review
human oversight expectations
escalation pathways for uncertain use cases
Responsible AI governance should make the right behavior easier than the risky behavior.
Start With an AI Use Inventory
Organizations cannot manage what they cannot see.
The first step is to identify where AI is already being used. This should include both formal vendor tools and informal employee use of generative AI.
An AI inventory should capture:
tool name
user or department
intended use
data entered into the tool
whether patient, research, confidential, or proprietary data are involved
whether outputs influence decisions or workflows
whether the tool is approved
whether a vendor agreement exists
whether monitoring or human review is in place
This does not need to begin as a punitive process. Leaders can frame the inventory as a way to understand workflow needs and create safer pathways for AI adoption.
Create a Practical AI Acceptable Use Policy
A clear AI acceptable use policy is one of the most important tools for reducing shadow AI risk.
The policy should define:
approved tools
prohibited tools or uses
rules for patient and confidential data
expectations for human review
documentation requirements
vendor approval pathways
use of AI-generated content
privacy and security expectations
escalation processes
consequences for high-risk unauthorized use
The policy should be specific enough to guide decisions but flexible enough to evolve as tools change.
For example, a policy may allow employees to use approved AI tools for internal brainstorming or administrative drafting but prohibit entering protected health information, proprietary research data, or confidential business information into unapproved platforms.
Match Oversight to Risk
Not all AI use requires the same level of review.
A low-risk administrative use case may need basic guidance and training. A tool that affects clinical decision-making, patient communication, trial recruitment, safety monitoring, or resource allocation requires stronger oversight.
Risk tiering should consider:
whether patient or regulated data are used
whether outputs are patient-facing
whether the tool influences clinical, operational, or research decisions
whether the use case affects access, eligibility, or prioritization
whether errors could cause harm
whether the tool has been validated
whether outputs are reviewed by a qualified human
NIST’s Generative AI Profile is a companion to the AI Risk Management Framework and is designed to help organizations incorporate trustworthiness considerations into the design, development, use, and evaluation of generative AI systems.
For healthcare, the principle is straightforward: the higher the potential impact, the stronger the governance should be.
Train Teams on Responsible AI Use
Policies alone are not enough.
Staff need practical training on how to use AI responsibly. Training should explain what shadow AI is, why it matters, what tools are approved, what data are restricted, and how employees can request review of a new AI use case.
Training should include examples that reflect real workflows, such as:
Can I use AI to summarize a meeting?
Can I paste a patient note into a chatbot?
Can I use AI to draft patient instructions?
Can I upload a clinical trial protocol?
Can I use AI to review a vendor proposal?
Can I use AI to draft marketing content?
Can I use AI to analyze de-identified data?
The goal is to reduce uncertainty. Employees are more likely to follow policy when they understand how it applies to their actual work.
Build an Approved Pathway for Innovation
Shadow AI often grows when employees do not know how to get AI tools reviewed.
Organizations should create a simple pathway for proposing, reviewing, and approving AI use cases. This may include:
a short AI intake form
risk tiering criteria
privacy and security review
vendor review when needed
clinical or operational review
bias and fairness assessment for higher-risk tools
approval by an AI governance committee when appropriate
monitoring expectations after deployment
This process should be clear and accessible. If the review process is too difficult, teams may avoid it.
Monitor and Update Over Time
Shadow AI governance is not a one-time project.
AI tools change quickly. Vendor platforms add new features. Staff workflows evolve.
New risks emerge. Organizations should regularly review their policies, approved tool lists, vendor agreements, monitoring processes, and training materials.
Leaders should ask:
Do we know where AI is currently being used?
Do staff know which AI tools are approved?
Have we clearly defined prohibited uses?
Are patient and confidential data protected?
Do we have a pathway for reviewing new AI use cases?
Are higher-risk tools monitored after deployment?
Do we have clear accountability when concerns arise?
If the answer to any of these questions is unclear, shadow AI risk is likely present.
Responsible AI Requires Visibility
Shadow AI is not a sign that employees are reckless. It is often a sign that employees see real workflow problems and are looking for faster ways to solve them.
Leaders should take that seriously.
The right response is not fear-based prohibition. It is governance that creates visibility, accountability, and safe pathways for innovation.
Organizations that lead in healthcare AI will not be those that ignore shadow AI or attempt to block every use of AI. They will be the organizations that define clear guardrails, educate their teams, and build practical oversight into everyday workflows.
Responsible AI requires visibility.
And visibility starts with governance.
Need Support Managing Shadow AI Risk?
CROSS Global Research & Strategy advises healthcare, pharma, digital health, and life sciences organizations on responsible AI strategy, governance, validation, and implementation.
We help teams develop AI acceptable use policies, assess shadow AI risk, create vendor review pathways, define governance workflows, and build oversight structures that support patient safety, privacy, equity, trust, and regulatory readiness.
To discuss how your organization can reduce shadow AI risk while supporting responsible innovation, contact CROSS Global Research & Strategy.
Suggested References
National Institute of Standards and Technology. Artificial Intelligence Risk Management Framework: Generative Artificial Intelligence Profile. NIST AI 600-1. National Institute of Standards and Technology; 2024.
US Department of Health and Human Services. The HIPAA Security Rule. HHS.
OWASP. OWASP Top 10 for Large Language Model Applications. OWASP. 2023
Coalition for Health AI. Blueprint for Trustworthy AI Implementation Guidance and Assurance for Healthcare. Coalition for Health AI. 2026
URAC. Health Care AI: Accountability in Practice. URAC. 2026
Comments